Direvo Acquires AC Biotec

07-Nov-2007

DIREVO Biotech AG announced that it has acquired AC Biotec GmbH in an all cash transaction. AC Biotec will continue to operate as an independent, fully-owned subsidiary of Direvo Biotech with Dr. Simon Curvers continuing as Managing Director. This acquisition helps Direvo extend and expand its capabilities and offerings to its current customers as well to new customers in the industrial biotechnology and pharmaceutical markets.

AC Biotec GmbH, located in Jülich, Germany, is a provider of bioprocess development and contract manufacturing services to the industrial biotechnology and pharmaceutical markets. Established in 2001, AC Biotec offers development, optimization and application of fermentation and downstream processes using microbial and plant cell-based systems. This includes the complete scale of biotechnological processes, starting from multi-well plates and shake flasks up to pilot-scale stirred-tank-reactors.

"The acquisition of AC Biotec is a very important step in the transformation of Direvo's Industrial Biotechnology Business Unit into a more complete technology provider and to become a one stop shop in the design and development of superior bioengineered products and processes", stated Dr. Thomas von Rüden, CEO of Direvo. "This will also help Direvo to develop processes and scale up its own line of proprietary products in the future. On the pharmaceutical side of the business, AC Biotec's capabilities will expand Direvo's ability to supply customers with samples of its optimized products at the preclinical stage. We welcome Simon Curvers and his group to the Direvo Team. Direvo Biotech remains committed to its further growth both organically as well as by additional M&A activities."

https://www.bionity.com/en/news/73856/direvo-acquires-ac-biotec.html